Pulse Biosciences, Inc. (PLSE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.70-0.05 (-0.34%)
At close: 1:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 14.75 |
| Open | 14.74 |
| Bid | 14.65 x 1100 |
| Ask | 16.70 x 3200 |
| Day's Range | 14.57 - 15.07 |
| 52 Week Range | 5.11 - 17.77 |
| Volume | 22,276 |
| Avg. Volume | 94,535 |
| Market Cap | 372.52M |
| Beta (5Y Monthly) | 1.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.26 |
| Earnings Date | Nov 09, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.00 |
- Business Wire
Pulse Biosciences to Participate in Upcoming Investor Conferences
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulationâ„¢ (NPSâ„¢) technology, today announced plans to participate in three upcoming virtual investor conferences.
- Simply Wall St.
What Kind Of Investors Own Most Of Pulse Biosciences, Inc. (NASDAQ:PLSE)?
The big shareholder groups in Pulse Biosciences, Inc. (NASDAQ:PLSE) have power over the company. Generally speaking...
- Motley Fool
Pulse Biosciences, Inc. (PLSE) Q3 2020 Earnings Call Transcript
With that, I would now like to turn the call over to President and Chief Executive Officer, Darrin Uecker. Throughout these difficult times, our team has shown unwavering dedication in their efforts to bring our technology to the market.
© 2020 Verizon Media. All rights reserved.
